Biomerieux SA

FR

BIOXX

Health Care

9.51 ₽

Current price

Buy
9.51 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    168 / 663

  • Position in country

    339 / 834

  • Return on Assets, %

    6.2

    -11.9

  • Net income margin, %

    9.6

    -12.5

  • EBITDA margin, %

    21

    -2.5

  • Debt to Equity, %

    13.8

    15

  • Intangible assets and goodwill, %

    23.3

    3.9

  • Revenue CAGR 3Y, %

    5.6

    12.6

  • Revenue Y, % chg

    6

    4.6

  • P/E

    34.7

    28.3

  • P/BV

    3.2

    1.7

  • P/S

    3.3

    3.7

  • EV/S

    3.4

    3.2

  • EV/EBITDA

    17.1

    -0.2

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    1184.8

    66.5

  • Forward P/E

    24.7

    19.2

  • Dividend Yield, %

    0.9

    1.8

  • Expected dividend per share

    0.9

    0

  • Payout Ratio, %

    28

    17.3

  • Dividend Ex Date

    2024-06-10

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Biomerieux SA

    00%

  • Stryker Corp

    00%

  • Medtronic PLC

    00%

  • Edwards Lifesciences Corp

    00%

  • Siemens Healthineers AG

    00%

  • Abbott Laboratories

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    France

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    13276.9

  • Ticker

    BMXXY.PK

  • ISIN

    US09074E1010

  • IPO date

    2004-06-07

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-28

  • Date fact. publication of reports

    2023-12-31

Company Description

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: